[Acute toxicity and antihymenolepiac activity of the new drug feliram].
Mikhaĭlitsyn
F S
FS
Lebedeva
M N
MN
Gitsu
G A
GA
Lychko
N D
ND
D000284:Administration, Oral; D000818:Animals; D000871:Anthelmintics / Q000009:adverse effects* / Q000737:chemistry / Q000302:isolation & purification / Q000627:therapeutic use*; D001549:Benzamides / Q000009:adverse effects* / Q000737:chemistry / Q000302:isolation & purification / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D006925:Hymenolepiasis / Q000188:drug therapy; D048189:Hymenolepis nana; D051379:Mice; D009281:Naphthalenes / Q000009:adverse effects* / Q000737:chemistry / Q000302:isolation & purification / Q000627:therapeutic use*
D000871:Anthelmintics; D001549:Benzamides; C518361:N-(3-chloro-4-(4-chloronaphthyl-1-yloxy)phenyl)-2-hydroxy-3,5-dichlorobenzamide; D009281:Naphthalenes